Superior Reports Full Year and Fourth Quarter 2024 Financial Results. Achieved critical milestones in Company transformation.

Attributable net income for the period was $11.3 million compared to an attributable net loss of $92.3 million in Q4 2023.

Revenue Growth of 28%Expects 2025 Revenue of $126 Million to $130 Million Without Need for Additional Capital BELGRADE, MT / ACCESS Newswire / March 6, 2025 / Xtant Medical Holdings, Inc.

COSTA MESA, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- El Pollo Loco Holdings, Inc. (Nasdaq: LOCO) today announced financial results for the 13- and 52-week periods ended December 25, 2024.

Full Year Financial Results Sales growth of +5.1%Slight increase of the Current Operating Profit Key figures in € million 31/12/24 % of ...

Vertex Pharmaceuticals demonstrates resilience with robust CF franchise, new approvals, and diversification efforts. Read why ...